Closer adherence urged to improve AMD outcomes
Closer adherence to published protocols and more aggressive treatment of patients with neovascular age-related macular degeneration (AMD) could help to improve visual outcomes in these patients, according to Frank Holz MD.
Presenting data from the AURA study, an international retrospective analysis of the real-world utilisation of anti-VEGF therapy in neovascular AMD, Dr Holz told delegates attending the 13th EURETINA Congress that the clinical endpoints of the study were to evaluate changes in visual acuity and resource utilisation in terms of overall visits, visual acuity and OCT tests and treatment use, following anti-VEGF treatment.
Data from 2,227 patients were collated from centres in Canada, France, Germany, Ireland, Italy, the Netherlands, UK and Venezuela.
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.
Improving Clinical Management for nAMD and DME
Global survey data identify barriers and opportunities.
Are Postoperative Topical Antibiotic Drops Still Needed?
Cataract surgeons debate the benefits of intracameral cefuroxime prophylaxis.
Emerging Technology for Detecting Subclinical Keratoconus
Brillouin microscopy shows promise in clinical studies.
Knowing Iris Repair: Modified Trifold Technique
Part eight of our series covers the modified trifold technique for large iris defects.
It’s All About Biomechanics!
Increasing the pool of patients eligible for refractive surgery.
Uncovering More Safe and Quick Options
Different strategies, such as PresbyLASIK, can offer presbyopes good outcomes.
Topography-Guided PRK for Keratoconus
Improving visual acuity in patients with keratoconus.
Defining AMD Treatment Protocol
Treatments trending to fewer injections for better results.